VELSIPITY® (etrasimod) for Adults with Moderate to Severe UC | Risk …
Discover VELSIPITY®, a once-daily oral prescription medicine that treats moderately to severely active ulcerative colitis (UC) in adults. See risks & benefits.
See what VELSIPITY can offer your patients with UC
Discover what VELSIPITY® (etrasimod) moderate to severe ulcerative colitis treatment can offer your adult patients. See safety info.
Managing Ulcerative Colitis With Velsipity - WebMD
Aug 19, 2024 · Velsipity (Vel-sip-itee) was approved in 2023 to treat moderate to severe ulcerative colitis in adults. How Does It Work?
U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to ...
Oct 13, 2023 · Approval of oral, once-daily VELSIPITY based on favorable safety and efficacy data from the ELEVATE UC Phase 3 trials Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and …
VELSIPITY™ Receives Health Canada Approval for Adults with ... - Pfizer
Apr 24, 2024 · A once-daily oral treatment, VELSIPITY is for adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant …
FDA Approves Etrasimod for Moderately to Severely Active Ulcerative Colitis
The US Food and Drug Administration (FDA) has approved etrasimod (Velsipity) 2 mg for adults with moderately to severely active ulcerative colitis (UC).
Clinical Overview: Etrasimod for Ulcerative Colitis
Nov 1, 2023 · This treatment option presents a distinctive blend of qualities that could potentially address the long-standing unmet requirements of patients with UC. Numerous treatments for UC …
Etrasimod Receives Strong Recommendation in the ACG Clinical …
“The inclusion of etrasimod in the 2025 American College of Gastroenterology (ACG) Clinical Guideline for Adult Ulcerative Colitis, with a strong recommendation, is a clear recognition of its clinical efficacy …
Oral Etrasimod Approved for Moderately to Severely Active Ulcerative ...
Oct 17, 2023 · The FDA has approved oral, once-daily etrasimod (Velsipity), a selective sphingosine-1-phosphate (S1P) receptor modulator for adults with moderately to severely active ulcerative colitis …
4 Types of Biologics for Ulcerative Colitis - Verywell Health
3 days ago · Biologic medications help reduce inflammation in ulcerative colitis. If you're new to biologics, infliximab might be your first option for ulcerative colitis. Humira lets you take your …